Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Bone Biologics Corp chart...

About the Company

We do not have any company description for Bone Biologics Corp at the moment.

Exchange

Nasdaq

$M

Total Revenue

4

Employees

$1M

Market Capitalization

-0.65

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $BBLG News

BBLG Bone Biologics Corporation

6d ago, source: Seeking Alpha

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s NELL-1/DBM, an osteopromotive recombinant ...

Bone Biologics Corp.

27d ago, source: CNN

Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative ...

Bone Biologics Reports Progress With NB1 Clinical Program

1mon ago, source: Stockhouse

Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, reports progress with advancing its product candidate NB1 into human clinical testing for ...

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

1mon ago, source: ADVFN

Brings 20+ years of experience in finance and business operations at both public and private life sciences companies Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq ...

Spine surgeons see promise in biologics, regenerative medicine

10d ago, source: Becker's Spine Review

Inductive agents like bone morphogenetic proteins (BMPs) and newly researched peptide enhanced bone grafts are being used to enhance the bone healing process and improve the success rate of spinal ...

Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights

28d ago, source: Finanznachrichten

Weber SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or the "Company") (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated ...

Bone Biologics Corporation (BBLG)

4d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Bone Biologics Corp BBLG

25d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bone Biologics Corp.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...